Moderna’s stock jumps 5% premarket after narrower-than-expected loss and revenue beat

Stock pops even as revenue falls sharply from last year as the world emerges from the COVID pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.